Drug delivery, formulation

© GettyImages/Mohammed Haneefa Nizamudeen

Setback for Novartis drug in advanced lung cancer trial

By Jane Byrne

Novartis reported today that a clinical trial of the drug, known as canakinumab, when combined with chemotherapy agent, docetaxel, failed to extend the lives of patients with advanced or metastatic non-small cell lung cancer compared to just chemotherapy...

(elenlabs/iStock via Getty Images Plus)

Latest FDA COVID-19 news

By Jenni Spinner

As the pandemic continues to impact the globe, the agency has kept busy issuing EUAs for potential treatments, and cited sellers of unapproved treatments.

Follow us

Product Innovations

Transforming Clinical Development

Transforming Clinical Development

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...